Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M.

BMC Med. 2016 Nov 3;14(1):160.

2.

Seasonal variation in haematological and biochemical reference values for healthy young children in The Gambia.

Okebe J, Mwesigwa J, Agbla SC, Sanya-Isijola F, Abubakar I, D'Alessandro U, Jaye A, Bojang K.

BMC Pediatr. 2016 Jan 11;16:5. doi: 10.1186/s12887-016-0545-6.

3.

Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.

Minchella PA, Armitage AE, Darboe B, Jallow MW, Drakesmith H, Jaye A, Prentice AM, McDermid JM.

J Nutr. 2015 Jun;145(6):1194-201. doi: 10.3945/jn.114.203158. Epub 2015 Apr 22.

4.

Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study.

Minchella PA, Armitage AE, Darboe B, Jallow MW, Drakesmith H, Jaye A, Prentice AM, McDermid JM.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1337-9. doi: 10.5588/ijtld.14.0143.

PMID:
25299867
5.

Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.

Hegedus A, Nyamweya S, Zhang Y, Govind S, Aspinall R, Mashanova A, Jansen VA, Whittle H, Jaye A, Flanagan KL, Macallan DC.

J Infect Dis. 2014 Sep 1;210(5):752-61. doi: 10.1093/infdis/jiu165. Epub 2014 May 5.

6.

Use of Self-Reported Adherence and Keeping Clinic Appointments as Predictors of Viremia in Routine HIV Care in the Gambia.

Peterson K, Menten J, Peterson I, Togun T, Okomo U, Oko F, Corrah T, Jaye A, Colebunders R.

J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):343-7. doi: 10.1177/2325957413500344. Epub 2013 Aug 30.

PMID:
23995297
7.

Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia.

Wilson H, de Jong BC, Peterson K, Jaye A, Kampmann B, Ota MO, Sutherland JS.

Clin Infect Dis. 2013 Aug;57(4):594-603. doi: 10.1093/cid/cit285. Epub 2013 May 3.

PMID:
23645847
8.

Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.

de Silva TI, Peng Y, Leligdowicz A, Zaidi I, Li L, Griffin H, Blais ME, Vincent T, Saraiva M, Yindom LM, van Tienen C, Easterbrook P, Jaye A, Whittle H, Dong T, Rowland-Jones SL.

Blood. 2013 May 23;121(21):4330-9. doi: 10.1182/blood-2012-12-472787. Epub 2013 Apr 4.

9.

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.

Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC.

Rev Med Virol. 2013 Jul;23(4):221-40. doi: 10.1002/rmv.1739. Epub 2013 Feb 26. Review.

PMID:
23444290
10.

Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.

McDermid JM, Hennig BJ, van der Sande M, Hill AV, Whittle HC, Jaye A, Prentice AM.

BMC Infect Dis. 2013 Jan 29;13:48. doi: 10.1186/1471-2334-13-48.

11.

Effect of HIV-2 infection on HIV-1 disease progression.

Vannberg FO, McDermid JM, Jaye A; MRC Gambia HIV Clinical Cohort Study.; Wellcome Trust Case Control Consortium 3..

N Engl J Med. 2012 Nov 15;367(20):1962; author reply 1962-3. doi: 10.1056/NEJMc1210334#SA3. No abstract available.

PMID:
23150975
12.

Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic.

de Silva TI, van Tienen C, Onyango C, Jabang A, Vincent T, Loeff MF, Coutinho RA, Jaye A, Rowland-Jones S, Whittle H, Cotten M, Hué S.

AIDS. 2013 Jan 2;27(1):125-34. doi: 10.1097/QAD.0b013e32835ab12c.

PMID:
23032414
13.

Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa.

Okomo U, Togun T, Oko F, Peterson K, Jaye A.

AIDS Res Ther. 2012 Oct 2;9(1):28. doi: 10.1186/1742-6405-9-28.

14.

Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?

Nyamweya S, Townend J, Zaman A, Steele SJ, Jeffries D, Rowland-Jones S, Whittle H, Flanagan KL, Jaye A.

PLoS One. 2012;7(9):e44411. doi: 10.1371/journal.pone.0044411. Epub 2012 Sep 10.

15.

Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.

Kong R, Li H, Georgiev I, Changela A, Bibollet-Ruche F, Decker JM, Rowland-Jones SL, Jaye A, Guan Y, Lewis GK, Langedijk JP, Hahn BH, Kwong PD, Robinson JE, Shaw GM.

J Virol. 2012 Nov;86(22):12115-28. doi: 10.1128/JVI.01632-12. Epub 2012 Aug 29.

16.

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

Okomo U, Togun T, Oko F, Peterson K, Townend J, Peterson I, Jaye A.

BMC Pediatr. 2012 Jul 8;12:95. doi: 10.1186/1471-2431-12-95.

17.

Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.

Zaidi I, Peterson K, Jeffries D, Whittle H, de Silva T, Rowland-Jones S, Jaye A, de Jong BC.

PLoS One. 2012;7(6):e39213. doi: 10.1371/journal.pone.0039213. Epub 2012 Jun 20.

18.

Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.

Njie-Jobe J, Nyamweya S, Miles DJ, van der Sande M, Zaman S, Touray E, Hossin S, Adetifa J, Palmero M, Burl S, Jeffries D, Rowland-Jones S, Flanagan K, Jaye A, Whittle H.

Vaccine. 2012 Mar 28;30(15):2543-50. doi: 10.1016/j.vaccine.2012.01.083. Epub 2012 Feb 5.

19.

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

Stewart B, Jobarteh ML, Sarge-Njie R, Alabi A, de Silva T, Peterson K, Peterson I, Whittle H, Rowland-Jones S, Jaye A, Cotten M, Mendy M.

BMC Res Notes. 2011 Dec 23;4:561. doi: 10.1186/1756-0500-4-561.

20.

Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.

de Silva TI, Aasa-Chapman M, Cotten M, Hué S, Robinson J, Bibollet-Ruche F, Sarge-Njie R, Berry N, Jaye A, Aaby P, Whittle H, Rowland-Jones S, Weiss R.

J Virol. 2012 Jan;86(2):930-46. doi: 10.1128/JVI.06126-11. Epub 2011 Nov 9.

Supplemental Content

Loading ...
Support Center